Literature DB >> 16428756

Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model.

Costi D Sifri1, Andrea Baresch-Bernal, Stephen B Calderwood, Christof von Eiff.   

Abstract

Small colony variants (SCVs) of Staphylococcus aureus are slow-growing morphological variants that have been implicated in persistent, relapsing, and antibiotic-resistant infections. The altered phenotype of SCVs in most strains has been attributed to defects in electron transport due to mutations in hemin or menadione biosynthesis. The pathogenic capacity of SCVs compared to phenotypically normal strains is variable depending on the attribute examined, with some studies showing reduced virulence of SCVs and others demonstrating normal or heightened virulence. Recently, the nematode Caenorhabditis elegans has been successfully employed as an alternative host to investigate virulence mechanisms of a variety of bacterial pathogens, including S. aureus. In this study, we show that clinical SCVs as well as hemB- and menD-deficient mutants of S. aureus are greatly reduced in virulence in the C. elegans infection model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428756      PMCID: PMC1360298          DOI: 10.1128/IAI.74.2.1091-1096.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney.

Authors:  Donna M Bates; Christof von Eiff; Peter J McNamara; Georg Peters; Michael R Yeaman; Arnold S Bayer; Richard A Proctor
Journal:  J Infect Dis       Date:  2003-04-30       Impact factor: 5.226

2.  Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens.

Authors:  Danielle A Garsin; Jacinto M Villanueva; Jakob Begun; Dennis H Kim; Costi D Sifri; Stephen B Calderwood; Gary Ruvkun; Frederick M Ausubel
Journal:  Science       Date:  2003-06-20       Impact factor: 47.728

3.  Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis.

Authors:  Ing-Marie Jonsson; Christof von Eiff; Richard A Proctor; Georg Peters; Cecilia Rydén; Andrzej Tarkowski
Journal:  Microb Pathog       Date:  2003-02       Impact factor: 3.738

4.  Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival.

Authors:  Greg A Somerville; Michael S Chaussee; Carrie I Morgan; J Ross Fitzgerald; David W Dorward; Lawrence J Reitzer; James M Musser
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype.

Authors:  Christof von Eiff; Peter McNamara; Karsten Becker; Donna Bates; Xiang-He Lei; Michael Ziman; Barry R Bochner; Georg Peters; Richard A Proctor
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

6.  Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants.

Authors:  Beata Sadowska; Agnieszka Bonar; Christof von Eiff; Richard A Proctor; Magdalena Chmiela; Wieslawa Rudnicka; Barbara Róźalska
Journal:  FEMS Immunol Med Microbiol       Date:  2002-02-18

7.  Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease.

Authors:  C von Eiff; K Becker; D Metze; G Lubritz; J Hockmann; T Schwarz; G Peters
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

8.  Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes.

Authors:  Pierre Vaudaux; Patrice Francois; Carmelo Bisognano; William L Kelley; Daniel P Lew; Jacques Schrenzel; Richard A Proctor; Peter J McNamara; G Peters; Christof Von Eiff
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants.

Authors:  Nicole Baumert; Christof von Eiff; Franziska Schaaff; Georg Peters; Richard A Proctor; Hans-Georg Sahl
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

10.  Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis.

Authors:  Costi D Sifri; Jakob Begun; Frederick M Ausubel; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  37 in total

1.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Triclosan-induced aminoglycoside-tolerant Listeria monocytogenes isolates can appear as small-colony variants.

Authors:  Vicky G Kastbjerg; Line Hein-Kristensen; Lone Gram
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

3.  Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.

Authors:  Joe Latimer; Sarah Forbes; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Staphylococcus saprophyticus surface-associated protein (Ssp) is associated with lifespan reduction in Caenorhabditis elegans.

Authors:  Florian Szabados; Amelie Mohner; Britta Kleine; Sören G Gatermann
Journal:  Virulence       Date:  2013-08-06       Impact factor: 5.882

5.  Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype.

Authors:  Jochen Seggewiss; Karsten Becker; Oliver Kotte; Martin Eisenacher; Mohammad Reza Khoschkhoi Yazdi; Andreas Fischer; Peter McNamara; Nahed Al Laham; Richard Proctor; Georg Peters; Matthias Heinemann; Christof von Eiff
Journal:  J Bacteriol       Date:  2006-09-15       Impact factor: 3.490

6.  Artificial Selection for Pathogenicity Mutations in Staphylococcus aureus Identifies Novel Factors Relevant to Chronic Infection.

Authors:  Kathryn McLean; Elizabeth A Holmes; Kelsi Penewit; Duankun K Lee; Samantha R Hardy; Mingxin Ren; Maxwell P Krist; Kevin Huang; Adam Waalkes; Stephen J Salipante
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

7.  A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus.

Authors:  Christian Kohler; Christof von Eiff; Manuel Liebeke; Peter J McNamara; Michael Lalk; Richard A Proctor; Michael Hecker; Susanne Engelmann
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

8.  Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.

Authors:  Wei Gao; Kyra Chua; John K Davies; Hayley J Newton; Torsten Seemann; Paul F Harrison; Natasha E Holmes; Hyun-Woo Rhee; Jong-In Hong; Elizabeth L Hartland; Timothy P Stinear; Benjamin P Howden
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

9.  Proteome changes of Caenorhabditis elegans upon a Staphylococcus aureus infection.

Authors:  Annelies Bogaerts; Isabel Beets; Liesbet Temmerman; Liliane Schoofs; Peter Verleyen
Journal:  Biol Direct       Date:  2010-02-17       Impact factor: 4.540

10.  Steps toward broad-spectrum therapeutics: discovering virulence-associated genes present in diverse human pathogens.

Authors:  Chris J Stubben; Melanie L Duffield; Ian A Cooper; Donna C Ford; Jason D Gans; Andrey V Karlyshev; Bryan Lingard; Petra C F Oyston; Anna de Rochefort; Jian Song; Brendan W Wren; Rick W Titball; Murray Wolinsky
Journal:  BMC Genomics       Date:  2009-10-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.